Our studies in cancer biology and pediatric oncology are focused on cellular plasticity, a phenomenon that relates both to the fundamental mechanisms of cancer pathogenesis and to the development of improved rational therapies. Detailed information about our research is available at http://alexkentsis.net.
Alex Kentsis, MD, PhD
Research FocusCancer biologist and pediatric oncologist Alex Kentsis leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
- MD, Mount Sinai School of Medicine
- PhD, New York University
- Ramaswamy K, Spitzer B, Kentsis A. Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. Front Oncol, 2015.
- McGee SF, Kornblau SM, Qiu Y, Look AT, Zhang N, Yoo S, Coombes KR, Kentsis A. Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia. Leukemia, 2015.
- Physician-Scientist Award, American Society for Clinical Investigation (2015)
- Scholar Award, American Society of Hematology (2014)
- Career Award for Medical Scientists, Burroughs Wellcome Fund (2013)
- Young Investigator Award, American Society for Pediatric Hematology/Oncology (2013)
- Young Investigator Award, Alliance for Clinical Trials in Oncology (2012)
- Research Award, Society of Pediatric Research (2009)
- Pediatric Hematology-Oncology Fellowship, Dana-Farber Cancer Institute and Boston Children’s Hospital, Harvard Medical School
- Residency in Pediatrics, Boston Children’s Hospital, Harvard Medical School
- MD and PhD, Mount Sinai School of Medicine and New York University
- AB and SM, University of Chicago